Congenital Disorders of Glycosylation

Purpose: Qualitative interpretation of sialotransferrin profiles in the screening for Congenital Disorders of Gycosylation (CDG)
Scientific Expert: Dr. D.J. Lefeber e-mail: D.Lefeber@neuro.umcn.nl
Scheme Organiser: Dr. C. Weykamp e-mail: c.w.weykamp@skbwinterswijk.nl
Analytes: Sialotransferrin isoforms
Number of Specimens/Year: 6
Matrix of the Specimens: Lyophilised Human plasma/serum
Volume/Specimen: 20 microL; in case of insufficient volume, 40microL could be requested
Number of Shipments/Year: One shipment of 6 samples per year
Submission of Results: Per email
Reports: Generated by D.J.Lefeber
Certificate:
Number of Participants: 46
Status of the Scheme: Pilot since 2008, official in 2010
Geographic Area: Worldwide
Limitation Participation: None
Cost/Year: 241 EURO (2013)
How to subscribe: Dr. Sara Gardner, e-mail: admin@erndim.org
Annual report: Click here for the annual reports
print